Osteocyte — A new target for the treatment of osteoporosis / 中华内分泌代谢杂志
Xiyu WU; Xianping WU; Eryuan LIAO.
Chinese Journal of Endocrinology and Metabolism
; (12): 627-630, 2013.
Artículo
en Zh
| WPRIM | ID: wpr-437708
The osteocyte has been found to be an orchestrator of bone remodeling.The damage of bone leads to osteocyte apoptosis.Sclerostin secreted by osteocyte causes feedback inhibition of bone formation,so inhibition of sclerostin expression has become a new target of treatment for osteoporosis.It seems resonable to direct clinical practise and treatment of metabolic bone diseases through understanding the function of osteocyte in the process of bone remodeling.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados